Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon vs. Placebo in Hospitalized Adult Patients With ModerateCOVID-19

NCT04708158 is registered in ClinicalTrials.gov with Genova Inc. as lead sponsor.

NCT NCT04708158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon vs. Placebo in Hospitalized Adult Patients With ModerateCOVID-19
Lead sponsor
Genova Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
March 25, 2021
Completion date
April 30, 2023
Enrollment
385 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

covid19